1-13 of 13
Ling Tian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P4-01-21: Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination With Fulvestrant or Letrozole and Goserelin in Patients With HR+, HER2– Advanced Breast Cancer

JiaJie Shi, Wei Li, Zhongsheng Tong, Aimin Zang, Xiaohua Zeng, Shui Wang, Tao Huang, Ying Wang, Yanqiu Song, Lihua Kang, Zheng Lv, Yehui Shi, Hua Yang, Jing Wu, Yongmei Yin, Yan Liang, Jie Tan, Jie Ming, Yaping Yang, Simin Luo, Xiujuan Gui, Ai-Min Hui, Zhuli Wu, Ling Tian, Yuchen Yang, Lei Diao, Wenjing Zhang, Yongjiao Zhang, Yunjiang Liu
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P4-01-21.
https://doi.org/10.1158/1538-7445.SABCS22-P4-01-21
Published: 01 March 2023
View article titled, Abstract P4-01-21: Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination With Fulvestrant or Letrozole and Goserelin in Patients With HR+, HER2– Advanced Breast Cancer
Journal Articles

Abstract CT117: Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2- advanced breast cancer (ABC)

Jian Zhang, Xiaojia Wang, Xian Wang, Aimin Hui, Zhuli Wu, Ling Tian, Changjiang Xu, Yuchen Yang, Wenjing Zhang, Xichun Hu
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT117.
https://doi.org/10.1158/1538-7445.AM2021-CT117
Published: 01 July 2021
View article titled, Abstract CT117: Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2- advanced breast cancer (ABC)
Journal Articles

Abstract 1825: Jab1/Csn5 a new target in the resistant mechanism to HER2-targeted therapies for breast cancer

Francois X. Claret, Thuy Vu, Terry J. Shackleford, Jennifer Allensworth, Qingxiu Zhang, Ling Tian, Ronghua Zhang
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1825.
https://doi.org/10.1158/1538-7445.AM2014-1825
Published: 01 October 2014
View article titled, Abstract 1825: Jab1/Csn5 a new target in the resistant mechanism to HER2-targeted therapies for breast cancer
Journal Articles

Abstract 1912: Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer

Thuy T. Vu, Terry Shackleford, Qingxiu Zhang, Do-Youn Oh, Zhou Fuling, Yunbao Pan, Ling Tian, Ilias Drakos, Georgios Rassidakis, Xiao-Feng Le, Aysegul Sahin, Timothy Kute, Francois Claret
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1912.
https://doi.org/10.1158/1538-7445.AM2012-1912
Published: 15 April 2012
View article titled, Abstract 1912: Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer
Journal Articles

Abstract 1855: Jab1/CSN5 a negative regulator of p27 plays a role in the pathogenesis and cisplatin sensitivity of nasopharyngeal carcinoma

Yunbao Pan, Qingxiu Zhang, Ling Tian, Xin Wang, Xiaohang Fan, Huizhong Zhang, Huiling Yang, Francois X. Claret
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1855.
https://doi.org/10.1158/1538-7445.AM2012-1855
Published: 15 April 2012
View article titled, Abstract 1855: Jab1/CSN5 a negative regulator of p27 plays a role in the pathogenesis and cisplatin sensitivity of nasopharyngeal carcinoma
Journal Articles

Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma

Yunbao Pan, Qingxiu Zhang, Ling Tian, Xin Wang, Xiaohang Fan, Huizhong Zhang, Francois X. Claret, Huiling Yang
Journal: Cancer Research
Cancer Res (2012) 72 (7): 1890–1900.
https://doi.org/10.1158/0008-5472.CAN-11-3472
Published: 01 April 2012
View article titled, Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma
Open the PDF for Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract #824: p27Kip1 protein levels predict dasatinib-induced potentiation of paclitaxel activity in human ovarian cancer cells

Xiao-Feng Le, Weiqun Mao, Qingxiu Zhang, Ling Tian, Ahmed Ahmed, Francois Claret, Robert Bast
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 824.
Published: 01 May 2009
View article titled, Abstract #824: p27Kip1 protein levels predict dasatinib-induced potentiation of paclitaxel activity in human ovarian cancer cells
Journal Articles

Role of JAB1 in resistance to Trastuzumab treatment

Terry Shackleford, Ling Tian, Anita Korapati, Qingxiu Zhang, Timothy Kute, Francois Claret
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5239.
Published: 01 May 2007
View article titled, Role of JAB1 in resistance to Trastuzumab treatment
Journal Articles

Potential Role of Jun Activation Domain–Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma

Maria A. Kouvaraki, Anita L. Korapati, George Z. Rassidakis, Ling Tian, Qingxiu Zhang, Paul Chiao, Linus Ho, Douglas B. Evans, François X. Claret
Journal: Cancer Research
Cancer Res (2006) 66 (17): 8581–8589.
https://doi.org/10.1158/0008-5472.CAN-06-0975
Published: 01 September 2006
View article titled, Potential Role of Jun Activation Domain–Binding Protein 1 as a Negative Regulator of p27<sup>kip1</sup> in Pancreatic Adenocarcinoma
Open the PDF for Potential Role of Jun Activation Domain–Binding Protein 1 as a Negative Regulator of p27<sup>kip1</sup> in Pancreatic Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma

Francisco Vega, L. Jeffrey Medeiros, Vasiliki Leventaki, Coralyn Atwell, Jeong Hee Cho-Vega, Ling Tian, Francois-Xavier Claret, George Z. Rassidakis
Journal: Cancer Research
Cancer Res (2006) 66 (13): 6589–6597.
https://doi.org/10.1158/0008-5472.CAN-05-3018
Published: 03 July 2006
View article titled, Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma
Open the PDF for Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Potential role of Jun activation domain-binding protein 1 (JAB1) as a negative regulator of P27KIP1 in pancreatic adenocarcinoma

Maria Kouvaraki, George Z. Rassidakis, Anita Korapati, Ling Tian, Paul Chiao, Linus Ho, Douglas B. Evans, Francois-Xavier Claret
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1277–1278.
Published: 01 May 2005
View article titled, Potential role of Jun activation domain-binding protein 1 (JAB1) as a negative regulator of P27<sup>KIP1</sup> in pancreatic adenocarcinoma
Journal Articles

Jun Activation Domain-binding Protein 1 Expression in Breast Cancer Inversely Correlates with the Cell Cycle Inhibitor p27Kip1

Maria A. Kouvaraki, George Z. Rassidakis, Ling Tian, Rakesh Kumar, Christos Kittas, François-Xavier Claret
Journal: Cancer Research
Cancer Res (2003) 63 (11): 2977–2981.
Published: 01 June 2003
View article titled, Jun Activation Domain-binding Protein 1 Expression in Breast Cancer Inversely Correlates with the Cell Cycle Inhibitor p27<sup>Kip1</sup>
Open the PDF for Jun Activation Domain-binding Protein 1 Expression in Breast Cancer Inversely Correlates with the Cell Cycle Inhibitor p27<sup>Kip1</sup> in another window
Journal Articles

Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2

Jing-Mei Su, Yu-Quan Wei, Ling Tian, Xia Zhao, Li Yang, Qiu-Ming He, Yu Wang, You Lu, Yang Wu, Fen Liu, Ji-Yan Liu, Jin-Liang Yang, Yan-Yan Lou, Bing Hu, Ting Niu, Yan-Jun Wen, Fei Xiao, Hong-Xin Deng, Jiong Li, Bing Kan
Journal: Cancer Research
Cancer Res (2003) 63 (3): 600–607.
Published: 01 February 2003
View article titled, Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2
Open the PDF for Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2 in another window